These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1623716)

  • 1. Contraceptive efficacy of polyester-induced azoospermia in normal men.
    Shafik A
    Contraception; 1992 May; 45(5):439-51. PubMed ID: 1623716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men.
    Mieusset R; Bujan L
    Int J Androl; 1994 Aug; 17(4):186-91. PubMed ID: 7995654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin injection, a new contraceptive method: experimental study.
    Shafik A
    Contraception; 1994 Aug; 50(2):191-9. PubMed ID: 7956218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testicular suspension as a method of male contraception: technique and results.
    Shafik A
    Adv Contracept Deliv Syst; 1991; 7(3-4):269-79. PubMed ID: 12284770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible physiological bases for contraceptive techniques in the male.
    Setchell BP
    Hum Reprod; 1994 Jun; 9(6):1081-7. PubMed ID: 7962380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonographic caput epididymis diameter is reduced in non-obstructive azoospermia compared with normozoospermia but is not predictive for successful sperm retrieval after TESE.
    Pezzella A; Barbonetti A; D'Andrea S; Necozione S; Micillo A; Di Gregorio A; Francavilla F; Francavilla S
    Hum Reprod; 2014 Jul; 29(7):1368-74. PubMed ID: 24812316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrovasogram in normal and vasectomized men and patients with obstructive azoospermia and absent vas deferens.
    Shafik A
    Arch Androl; 1996; 36(1):67-79. PubMed ID: 8824668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three new methods for male contraception.
    Shafik A
    Asian J Androl; 1999 Dec; 1(4):161-7. PubMed ID: 11225888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in male contraception.
    Shafik A
    Arch Androl; 2000; 45(3):155-67. PubMed ID: 11111864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular function in a birth cohort of young men.
    Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
    Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different types of textile fabric on spermatogenesis. I. Electrostatic potentials generated on surface of human scrotum by wearing different types of fabric.
    Shafik A; Ibrahim IH; el-Sayed EM
    Andrologia; 1992; 24(3):145-7. PubMed ID: 1503251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic epididymal and testicular sperm recovery and genetic aspects in azoospermic men.
    Westlander G; Hamberger L; Hanson C; Lundin K; Nilsson L; Söderlund B; Werner C; Bergh C
    Hum Reprod; 1999 Jan; 14(1):118-22. PubMed ID: 10374107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.